Tanvi Foods (India) Ltd - 540332 - Receipt Of Approval From USFDA
Receipt of approval from USFDA29-06-2024
Tanvi Foods (India) Ltd - 540332 - Receipt Of Approval From USFDA
Receipt of approval from USFDATanvi Foods (India) Ltd - 540332 - Statement Of Deviation & Variation As At 31.03.2024
Statement of Deviation & Variation as at 31.03.2024Tanvi Foods (India) Ltd - 540332 - Financial Results For The Period Ended 31.03.2024
Financial Results for the period ended 31.03.2024Tanvi Foods (India) Ltd - 540332 - Board Meeting Intimation for Approval Of Financial Results For The Half Year And Year Ended 31.03.2024
Tanvi Foods (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the audited financial statements for the half year and year ended 31.03.2024Tanvi Foods (India) Ltd - 540332 - Compliance Certificate Under Regulation 40(9)
Compliance Certificate under Regulation 40(9)Tanvi Foods (India) Ltd - 540332 - Compliance Certificate For The Year Ended 31.03.2024
Compliance Certificate under Reg 7(3) for the year ended 31.03.2024Tanvi Foods (India) Ltd - 540332 - Commencement Of Operations At The New Automated Manufacturing Unit At Seetharampuram, Andhra Pradesh
Commencement of operations at the new state of art automated manufacturing unit at Seetharampuram, Andhra PradeshTanvi Foods (India) Ltd - 540332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Outcome of Investor Conference and PresentationTanvi Foods (India) Ltd - 540332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that Mr. Sri Nagaveer Adusumilli, Chairman & Managing Director of the Company will be participating as a speaker in person, on behalf of the Company in the Investor conference being conducted in Hyderabad